PCDHA1 High Expression is Associated With Poor Prognosis and Correlated With Immune Cell Infiltration in Breast Cancer

被引:2
作者
Du, Jiawei [1 ]
Wu, Kaidi [1 ,2 ]
机构
[1] Jinzhou Med Univ, Ultrasonog Dept, Affiliated Hosp 1, Jinzhou, Liaoning, Peoples R China
[2] Jinzhou Med Univ, Ultrasonog Dept, Affiliated Hosp 1, 2 Sect 5,Renmin St, Jinzhou 121001, Liaoning, Peoples R China
关键词
Immune infiltration; Prognostic biomarker; TCGA-BRCA; Protocadherin Alpha 1; CHEMOKINE; GENES; ORGANIZATION; FAMILY; CXCL17; ACTS;
D O I
10.1016/j.clbc.2023.02.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High expression of PCDHA1 was related to poor prognosis in breast cancer patients. Upregulated PCDHA1 expression was correlated to strong activated NK cell infiltration and weak resting NK cell infiltration. Expression of chemokines CCL28, CXCL17, and receptor CCR9 were positively correlated with PCDHA1 expression in breast cancer. PCDHA1 overexpression enhanced breast cancer cell proliferation and invasion. Introduction: Breast cancer (BC) remains one of the biggest threats to women's health. Protocadherin gene Protocadherin Alpha 1 (PCDHA1) is abnormally highly expressed in breast cancer tissues. However, the biological role of PCDHA1 in breast cancer has not been fully elucidated and the relationship with the immune microenvironment needs to be further studied. Materials and Methods: TCGA-BRCA gene expression profiles were used to characterize PCDHA1. Kaplan-Meier method was used to estimate PCDHA1 prognosis potential. Gene set enrichment analysis (GSEA) analysis was performed to determine the signaling pathways altered by PCDHA1 aberrant expression. The correlations between PCDHA1 and immune cell infiltration levels were analyzed by CIBERSORT. Wilcoxon's rank-sum test was used to identify chemokine and chemokine receptors significantly associated with PCDHA1. The CCK8 assay and the transwell invasion assay were occupied to evaluate the effect of PCDHA1 overexpression on BC cells. Results: Survival analysis revealed PCDHA1 overexpression was associated with poor prognosis in BC. Enrichment analysis uncovered several metabolism pathways were activated by PCDHA1 overexpression. Moreover, PCDHA1 was positively correlated with activated NK cells but negatively correlated with resting NK cells infiltration. In addition, chemokines CCL28, CXCL17, and receptor CCR9 expression were associated with PCDHA1 overexpression. The CCK8 assay and the transwell invasion assay proved that PCDHA1 overexpression enhanced MCF-7 and MDA-MB-231 cell proliferation and invasion. Conclusion: This study demonstrated that PCDHA1 effectively predicted BC prognosis. Upregulated PCDHA1 activated metabolism pathways, and promoted NK cells and chemokines. PCDHA1 overexpression enhanced BC cell proliferation and invasion. Therefore, an understanding of PCDHA1's function in BC may yield insights into the mechanisms of BC development.
引用
收藏
页码:397 / 407
页数:11
相关论文
共 45 条
[1]   Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer [J].
Ademuyiwa, Foluso O. ;
Chen, Ina ;
Luo, Jingqin ;
Rimawi, Mothaffar F. ;
Hagemann, Ian S. ;
Fisk, Bryan ;
Jeffers, Gejae ;
Skidmore, Zachary L. ;
Basu, Anamika ;
Richters, Megan ;
Ma, Cynthia X. ;
Weilbaecher, Katherine ;
Davis, Jennifer ;
Suresh, Rama ;
Peterson, Lindsay L. ;
Bose, Ron ;
Bagegni, Nusayba ;
Rigden, Caron E. ;
Frith, Ashley ;
Rearden, Timothy P. ;
Hernandez-Aya, Leonel F. ;
Roshal, Anna ;
Clifton, Katherine ;
Opyrchal, Mateusz ;
Akintola-Ogunremi, Olaronke ;
Lee, Byung Ha ;
Ferrando-Martinez, Sara ;
Church, Sarah E. ;
Anurag, Meenakshi ;
Ellis, Matthew J. ;
Gao, Feng ;
Gillanders, William ;
Griffith, Obi L. ;
Griffith, Malachi .
BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (01) :187-202
[2]   Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine [J].
Amersi, Farin F. ;
Terando, Alicia M. ;
Goto, Yasufumi ;
Scolyer, Richard A. ;
Thompson, John F. ;
Tran, Andy N. ;
Faries, Mark B. ;
Morton, Donald L. ;
Hoon, Dave S. B. .
CLINICAL CANCER RESEARCH, 2008, 14 (03) :638-645
[3]   Protocadherin B9 Is Associated with Tumorigenesis and Cancer Progression in Colorectal Cancer [J].
Asai, Ryuichi ;
Taniyama, Daiki ;
Oue, Naohide ;
Yamamoto, Yuji ;
Akabane, Shintaro ;
Sentani, Kazuhiro ;
Ohdan, Hideki ;
Yoshida, Kazuhiro ;
Yasui, Wataru .
PATHOBIOLOGY, 2022, 89 (04) :214-221
[4]   Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment [J].
Azizi, Elham ;
Carr, Ambrose J. ;
Plitas, George ;
Cornish, Andrew E. ;
Konopacki, Catherine ;
Prabhakaran, Sandhya ;
Nainys, Juozas ;
Wu, Kenmin ;
Kiseliovas, Vaidotas ;
Setty, Manu ;
Choi, Kristy ;
Fromme, Rachel M. ;
Phuong Dao ;
McKenney, Peter T. ;
Wasti, Ruby C. ;
Kadaveru, Krishna ;
Mazutis, Linas ;
Rudensky, Alexander Y. ;
Pe'er, Dana .
CELL, 2018, 174 (05) :1293-+
[5]   Cancer stem cell-immune cell crosstalk in tumour progression [J].
Bayik, Defne ;
Lathia, Justin D. .
NATURE REVIEWS CANCER, 2021, 21 (08) :526-536
[6]   Cancer cells educate natural killer cells to a metastasis-promoting cell state [J].
Chan, Isaac S. ;
Knutsdottir, Hildur ;
Ramakrishnan, Gayathri ;
Padmanaban, Veena ;
Warrier, Manisha ;
Ramirez, Juan Carlos ;
Dunworth, Matthew ;
Zhang, Hao ;
Jaffee, Elizabeth M. ;
Bader, Joel S. ;
Ewald, Andrew Josef .
JOURNAL OF CELL BIOLOGY, 2020, 219 (09)
[7]  
Cortes J, 2020, LANCET, V396, P1817, DOI 10.1016/S0140-6736(20)32531-9
[8]   Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways [J].
Dallosso, A. R. ;
Oster, B. ;
Greenhough, A. ;
Thorsen, K. ;
Curry, T. J. ;
Owen, C. ;
Hancock, A. L. ;
Szemes, M. ;
Paraskeva, C. ;
Frank, M. ;
Andersen, C. L. ;
Malik, K. .
ONCOGENE, 2012, 31 (40) :4409-4419
[9]   Circulating CD56bright NK cells inversely correlate with survival of melanoma patients [J].
de Jonge, Kaat ;
Ebering, Anna ;
Nassiri, Sina ;
Maby-El Hajjami, Helene ;
Ouertatani-Sakouhi, Hajer ;
Baumgaertner, Petra ;
Speiser, Daniel E. .
SCIENTIFIC REPORTS, 2019, 9 (1)
[10]   Identification and Prognostic Value Exploration of Cyclophosphamide (Cytoxan)-Centered Chemotherapy Response-Associated Genes in Breast Cancer [J].
Du, Jiawei ;
Dong, Yanru ;
Li, Yuhong .
DNA AND CELL BIOLOGY, 2021, 40 (11) :1356-1368